Dr Connolly highlights the cautious patient selection and the significance of reducing hematoma expansion for improved outcomes in cases of intracerebral hemorrhage (ICH) associated with the use of a reversal agent for factor Xa inhibitors.
Related Keywords
Stuartj Connolly , , Stroke , Bleeding , Anticoagulant , Hematoma Expansion , Rich , Intracerebral Hemorrhage , Doac , Direct Oral Anticoagulant , Annexai Study , Hemostatic Efficacy , Factorx Inhibitor , Risk Factors , Baseline Nih , Baseline Nih Score , Andexanet Alfa , 4 Factor Prothrombin Complex Concentrate , 4fpcc ,
comparemela.com © 2020. All Rights Reserved.